HEALTHNET HOMECARE (UK) LIMITED
Get an alert when HEALTHNET HOMECARE (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-01-31 (in 8mo)
Last filed for 2025-04-30
Confirmation statement due
2026-10-14 (in 5mo)
Last made up 2025-09-30
Watchouts
None on the register
Cash
£12M
+9.4% vs 2024
Net assets
£19M
+39.3% vs 2024
Employees
429
+33.2% vs 2024
Profit before tax
£8M
+24.4% vs 2024
Name history
Renamed 1 time since incorporation
- HEALTHNET HOMECARE (UK) LIMITED 2017-10-26 → present
- TOTAL MEDICATION MANAGEMENT SERVICES LIMITED 2009-03-24 → 2017-10-26
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · latest reflected 2025-04-30
| Metric | Trend | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £692,565,000 | £966,827,000 | |
| Operating profit | — | — | — | — | £6,802,000 | £9,607,000 | |
| Profit before tax | — | — | — | — | £6,599,000 | £8,211,000 | |
| Net profit | — | — | — | — | £4,824,000 | £5,463,000 | |
| Cash | — | — | — | — | £10,808,000 | £11,826,000 | |
| Total assets less current liabilities | — | — | — | — | £14,909,000 | £20,864,000 | |
| Net assets | — | — | — | — | £13,887,000 | £19,350,000 | |
| Equity | £2,884,000 | £3,982,000 | £5,976,000 | £9,063,000 | £13,887,000 | £19,350,000 | |
| Average employees | — | — | — | — | 322 | 429 | |
| Wages | — | — | — | — | £13,532,000 | £17,028,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | 1.0% | 1.0% | |
| Net margin | — | — | — | — | 0.7% | 0.6% | |
| Return on capital employed | — | — | — | — | 45.6% | 46.0% | |
| Interest cover | — | — | — | — | 12.17x | 5.42x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors constantly review the risks and uncertainties in the market place, in the wider group and at entity level. The group of which the Company is a part operates in a niche market area which is driven by the general public's health needs. Whilst it remains a very competitive area, the business does not necessarily face the same level of risk and uncertainties as those experienced in the wider economy. After considering the financial position of the Company at the time of approving the financial statements and the Company's financial forecasts up to April 2027, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus the Directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Group structure
- HEALTHNET HOMECARE (UK) LIMITED · parent
- LF & E Refrigerated Transport Limited 100%
- Healthcare Anywhere Limited 100%
Significant events
- “In May 2024, Healthnet Homecare (UK) Limited, the Company, purchased 100% of the ordinary share capital of Healthcare Anywhere Limited for £140,000 in cash. Global Orphan Limited, a fellow group company, owned 50% of the ordinary share capital at the date of purchase and received £70,000 in return for its shares.”
- “On 29 October 2024, the entire share capital of Socius Pharma Group was purchased by Apollo 2024 Bidco Limited, the ultimate parent company of which is Apollo 2024 Topco Limited.”
- “Exceptional items consist of costs incurred related to the acquisition of the Socius Pharma group by the Apollo 2024 Topco group.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 21 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SHERRY, Julie Marie | Secretary | 2021-04-12 | — | — |
| CARVER, Christopher David | Director | 2021-04-12 | Feb 1977 | British |
| HINTON, Kerry | Director | 2017-06-23 | Mar 1971 | British |
| SHERRY, Julie Marie | Director | 2021-04-12 | Aug 1977 | British |
Show 21 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SMITH, Joseph | Secretary | 2011-05-16 | 2012-04-13 |
| SUCH, Martin John | Secretary | 2015-03-03 | 2015-12-01 |
| SWINHOE, Craig Robert | Secretary | 2015-12-01 | 2017-06-23 |
| TYLER, Julian Justin Michael | Secretary | 2017-06-23 | 2021-04-12 |
| DAULBY, Sarah Louise | Director | 2009-03-31 | 2010-10-26 |
| FISHER, Brian James | Director | 2015-03-03 | 2017-06-23 |
| GORDON, Michael Andrew | Director | 2021-04-12 | 2024-10-29 |
| HEELEY, Christopher David | Director | 2016-03-02 | 2018-02-16 |
| HIND, Nicholas John | Director | 2009-03-24 | 2012-04-13 |
| MURRAY, Gerard Thomas | Director | 2017-01-23 | 2017-06-23 |
| PEARCE, Ian Jeffrey | Director | 2012-10-17 | 2019-05-31 |
| RIGG, Christian Alexander | Director | 2016-03-08 | 2017-01-27 |
| RUSHTON, David Paul | Director | 2011-12-01 | 2012-04-10 |
| SANSON, David Alan | Director | 2017-03-01 | 2017-06-23 |
| SCAIFE, Andrew John | Director | 2011-05-16 | 2015-12-01 |
| SMITH, Joseph | Director | 2011-05-16 | 2012-04-13 |
| SODHA, Anand Rati Nitin | Director | 2021-04-12 | 2024-10-29 |
| SODHA, Anup | Director | 2017-06-23 | 2021-04-12 |
| SONPAL, Pritesh Ramesh | Director | 2017-06-23 | 2021-04-09 |
| STEPHENSON, Jill Tracey | Director | 2021-04-12 | 2024-10-29 |
| SUCH, Martin John | Director | 2011-05-16 | 2016-03-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Healthnet Homecare Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-06-23 | Active |
| Quantum Pharmaceutical Limited | Corporate entity | Voting 75–100% | 2017-03-22 | Ceased 2017-06-23 |
Filing timeline
Last 20 of 144 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-11-18 MA Memorandum articles
- 2024-11-18 RESOLUTIONS Resolution
- 2021-05-29 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-29 | AA | accounts | Accounts with accounts type full | |
| 2025-10-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-21 | AA | accounts | Accounts with accounts type full | |
| 2024-11-18 | MA | incorporation | Memorandum articles | |
| 2024-11-18 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-07 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-06 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-31 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-09-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-05 | AA | accounts | Accounts with accounts type full | |
| 2023-10-05 | CH01 | officers | Change person director company with change date | |
| 2023-10-05 | CH01 | officers | Change person director company with change date | |
| 2023-10-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-02 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-11-22 | AA | accounts | Accounts with accounts type full | |
| 2022-11-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-12-01 | AA | accounts | Accounts with accounts type full | |
| 2021-10-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-05-29 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-04-30 vs 2024-04-30
-
Turnover
+39.6%
£692,565,000 £966,827,000
-
Cash
+9.4%
£10,808,000 £11,826,000
-
Net assets
+39.3%
£13,887,000 £19,350,000
-
Employees
+33.2%
322 429
-
Operating profit
+41.2%
£6,802,000 £9,607,000
-
Profit before tax
+24.4%
£6,599,000 £8,211,000
-
Wages
+25.8%
£13,532,000 £17,028,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers